HYTN and SNDL to Collaborate on GMP-Compliant Vape Cartridge Development for Global Markets
January 21, 2025 19:30 ET
|
HYTN Innovations Inc.
VANCOUVER, British Columbia, Jan. 21, 2025 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or the “Company”), a company specializing in pharmaceutical-grade...
HYTN Secures Additional Permits to Expand International GMP Cannabis Exports
January 14, 2025 19:30 ET
|
HYTN Innovations Inc.
VANCOUVER, British Columbia, Jan. 14, 2025 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or the “Company”), a pharmaceutical company specializing in...
HYTN Announces Initial Purchase Order under Manufacturing Partnership with Industry-Leading SNDL
January 10, 2025 19:30 ET
|
HYTN Innovations Inc.
VANCOUVER, British Columbia, Jan. 10, 2025 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or the “Company”), a pharmaceutical company specializing in...
HYTN Announces Sale and Distribution of GMP Cannabis Products in the UK
December 16, 2024 08:00 ET
|
HYTN Innovations Inc.
VANCOUVER, British Columbia, Dec. 16, 2024 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) ("HYTN" or "the Company"), a pharmaceutical company specializing in the...
HYTN Receives Opening Order and Import Permits from the UK's 4C Labs, Prepares Products for Export
November 28, 2024 08:00 ET
|
HYTN Innovations Inc.
VANCOUVER, British Columbia, Nov. 28, 2024 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or “the Company”), a pharmaceutical company specializing in the...
HYTN Announces Marketing Program
November 08, 2024 17:40 ET
|
HYTN Innovations Inc.
VANCOUVER, British Columbia, Nov. 08, 2024 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or “the Company”), a company specializing in the pharmaceutical...
HYTN Expands GMP Capabilities with New Licensed Activity
October 09, 2024 08:00 ET
|
HYTN Innovations Inc.
VANCOUVER, British Columbia, Oct. 09, 2024 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or “the Company”), a pharmaceutical company specializing in the...
HYTN Files Business Acquisition Report
September 27, 2024 19:25 ET
|
HYTN Innovations Inc.
VANCOUVER, British Columbia, Sept. 27, 2024 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or “the Company”), a pharmaceutical company specializing in the...
HYTN Partners with the UK's 4C Labs, Validates GMP Certification
September 10, 2024 08:00 ET
|
HYTN Innovations Inc.
VANCOUVER, British Columbia, Sept. 10, 2024 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or “the Company”), a pharmaceutical company specializing in the...
HYTN Lists on the OTC Pink Market
July 29, 2024 08:00 ET
|
HYTN Innovations Inc.
VANCOUVER, British Columbia, July 29, 2024 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN | FSE: 85W0 | OTC PINK: HYTNF) “HYTN” or “the Company”, a pharmaceutical company specializing in the...